Skip to content

Robot Assisted Total Hip Arthroplasties

A Randomized Controlled, Multicenter Study for Patients Underwent Total Hip Arthroplasties Assisted by VTS Surgical Robotic System

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05947734
Enrollment
138
Registered
2023-07-17
Start date
2021-04-01
Completion date
2022-12-01
Last updated
2023-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Arthropathy

Brief summary

This is a randomized controlled, multicenter study. According to the inclusion criteria, volunteers were recruited from patients undergoing total hip arthroplasty. After signing the informed consent, the subjects were assigned to the experimental group and the control group through the central randomization system. The researchers will complete the total hip arthroplasty for patients in the experimental group with the assistance of surgical robotic system. The patients in the control group do not use the surgical robotic system. The proportion of acetabular abduction angle and anteversion angle in the lewinnek safe area is the primary outcome measurement. The operation time, WOMAC score, Harris score, SF-36 and dislocation rate are the secondary outcome measurements. The incidence of complications, devices and other adverse events were recorded.

Interventions

DEVICEVTS surgical robotic system

TheVTS surgical robotic system can accurately match the preoperative and intraoperative image data with the patient's anatomical structure on the operating table, track and locate the surgical instruments during the operation. With the help of the robotic arm, the surgeon can make the operation procedure more accurate and safer.

Sponsors

Qianfoshan Hospital
CollaboratorOTHER
Chifeng Municipal Hospital
CollaboratorOTHER
Peking University Third Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of primary hip osteoarthritis(OA), fracture of femoral neck (FFN),or secondary hip osteoarthritis due to developmental dysplasia of the hip (DDH), hip avascular necrosis (AVN), rheumatoid arthritis (RA), ankylosing spondylitis (AS), and coxa plana

Exclusion criteria

* Severe vascular diseases of the lower extremity Neuromuscular diseases Infectious diseases Severe dysfunctions of major organs Severe neurosensory deficiencies caused by spinal diseases Unable to receive CT/MRI scans

Design outcomes

Primary

MeasureTime frameDescription
Acetabular location accuracyWithin 1 week after surgeryProportion of abduction angle and anteversion angle of acetabular cup in lewinnek safe area

Secondary

MeasureTime frameDescription
the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)6 months after surgeryThe WOMAC is a self administered questionnaire to assess joint function and quality of life for patients with osteoarthritis; it consists of 24 items: pain (5 items), stiffness (2 items), and physical function (17 items). The higher the total score, the worse the patient's pain, stiffness, and functional limitations. The WOMAC is validated for various languages, including Chinese
Harris Hip Score (HHS)6 months after surgerya rating scale with a maximum of 100 points, including the domains of pain, function, deformity, and motion
Operation timeImmediately after surgeryTime from skin incision to wound closure
dislocation rate of hip joint6 months after surgerythe proportion of participants encountered with dislocation of hip joint after THA
adverse events or complications6 months after surgerythe rate of adverse events or complications in all the participants
36-Item Short Form Survey (SF-36)6 months after surgeryThe SF-36 is a multi-purpose survey designed to capture adult patients' perceptions of their own health and well-being.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026